<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//FR">
<HTML>
<HEAD>
 <LINK HRef="../CSS/ggrcm.css" Rel="stylesheet" Type="text/css">
 <META name="description" content="M&eacute;dicaments de la d&eacute;pendance aux opiac&eacute;s">
 <META name="keywords" content="M&eacute;dicaments de la d&eacute;pendance aux opiac&eacute;s, R&eacute;pertoire Comment&eacute; des M&eacute;dicaments (C.B.I.P. aslb)">
 <META name="GGR_Kruimelpad" content=" Systeme nerveux / Medicaments utilises dans le cadre de la dependance / ">
 <META name="GGR_HyrTree" content="10.5.3.">
 <cfinclude template="/include/SPC.cfm"/>
  <script SRC="/JS/jquery-1.3.2.min.js"></script>
  <script SRC="/JS/jquery.qtip-1.0.0-rc3.min.js"></script>
  <!---script SRC="/JS/qTip_FR.js"></script--->
 <TITLE>M&eacute;dicaments de la d&eacute;pendance aux opiac&eacute;s</TITLE>
</HEAD>

<BODY bgcolor="#FFFFFF" LeftMargin="0" RightMargin="0" TopMargin="0" BottomMargin="0" MarginWidth="0" MarginHeight="0" id="bodykw">
 <A Name="TopOfPage"></A>

  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%"><A HRef="../HeaderTxt/LeCBIP.htm">Le C.B.I.P.</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/NousContacter.htm">Nous contacter</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/Liens.htm">Sites Int&eacute;ressantes</A></TD>
   </TR> 
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%" Class="footer">Bon &agrave; savoir</TD>
    <TD Width="30%"><A HRef="../Index.htm"><B>Le R&eacute;pertoire</B></A></TD>
    <TD Width="30%" Class="footer">Folia</TD>
   </TR> 
   <TR> 
    <TD ColSpan="4"><HR></TD>
   </TR> 
  </TABLE> 

 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
  <TR>
   <TD vAlign="top" Width="260">
  <!--- begin van linker "tafel" met TOC --->
    <TABLE Width="260" Border="0" CellPadding="0" CellSpacing="0" BgColor="#DEFFD6" style="border: solid #000000 1px">
     <TR>
      <TD ColSpan="3" Align="center" BgColor="#008000">
       <FONT Face="Arial" Size="2" Color="#FFFFFF"><STRONG>Table des mati&egrave;res</STRONG></FONT></TD>
     </TR>
     <TR>
      <TD Width="3">&nbsp;</TD>
      <TD Width="256">
       <TABLE Width="100%" Border="0" CellPadding="2" CellSpacing="0">
        <TR>
         <TD  Colspan="2"><IMG SRC="../Images/Pixel_Transp.gif" Alt="" Width="1" Height="5" Border="0"></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">&nbsp;</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="/GGR/Index_Intro.cfm" Class="toc">Introduction</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">1.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_A.htm" Class="toc">Syst&egrave;me cardio-vasculaire</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">2.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_B.htm" Class="toc">Sang et coagulation</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">3.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_C.htm" Class="toc">Syst&egrave;me gastro-intestinal</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">4.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_D.htm" Class="toc">Syst&egrave;me respiratoire</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_E.htm" Class="toc">Syst&egrave;me hormonal</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">6.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_F.htm" Class="toc">Gyn&eacute;co-obst&eacute;trique</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">7.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_G.htm" Class="toc">Syst&egrave;me urog&eacute;nital</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">8.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_H.htm" Class="toc">Douleur et fi&egrave;vre</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">9.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_I.htm" Class="toc">Pathologies ost&eacute;o-articulaires</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">10.</TD>
         <TD vAlign="top" Class="toc"><A HRef="../MPG/MPG_J.htm" Class="toc">Syst&egrave;me nerveux</A></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">10.5.</TD>
         <TD vAlign="top" Class="toc"><A HRef="../MPG/MPG_JE.htm" Class="toc">&nbsp;M&eacute;dicaments utilis&eacute;s dans le cadre de la d&eacute;pendance</A></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr" BgColor="#FFFF99">10.5.3.</TD>
         <TD vAlign="top" Class="toc" BgColor="#FFFF99">&nbsp;&nbsp;M&eacute;dicaments de la d&eacute;pendance aux opiac&eacute;s</TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">10.5.3.1.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_JECA" Class="toc">&nbsp;&nbsp;&nbsp;M&eacute;thadone</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">10.5.3.2.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_JECB" Class="toc">&nbsp;&nbsp;&nbsp;Bupr&eacute;norphine</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">10.5.3.3.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_JECC" Class="toc">&nbsp;&nbsp;&nbsp;Naltrexone</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">10.5.3.4.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_JECD" Class="toc">&nbsp;&nbsp;&nbsp;Bupr&eacute;norphine + naloxone</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">11.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_K.htm" Class="toc">Infections</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">12.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_L.htm" Class="toc">Immunit&eacute;</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">13.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_M.htm" Class="toc">M&eacute;dicaments antitumoraux</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">14.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_N.htm" Class="toc">Min&eacute;raux, vitamines et toniques</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">15.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_O.htm" Class="toc">Dermatologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">16.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_P.htm" Class="toc">Ophtalmologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">17.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_Q.htm" Class="toc">Oto-Rhino-Laryngologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">18.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_R.htm" Class="toc">Anesth&eacute;sie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">19.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_S.htm" Class="toc">Agents de diagnostic</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">20.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_T.htm" Class="toc">M&eacute;dicaments divers</A><BR>
         </TD>
        </TR>
       </TABLE>
       <BR>
      </TD>
     </TR>
    </TABLE>
    <DIV class="normal_font">&nbsp; <strong>Nom de sp&eacute;cialit&eacute;:</strong></DIV>
    <table border="0" cellspacing="2" cellpadding="1" align="center">
     <tr>
      <td align=center class="letter"><A href="../Merk/MP_A.htm" class="letterlink">&nbsp;A&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_B.htm" class="letterlink">&nbsp;B&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_C.htm" class="letterlink">&nbsp;C&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_D.htm" class="letterlink">&nbsp;D&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_E.htm" class="letterlink">&nbsp;E&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_F.htm" class="letterlink">&nbsp;F&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_G.htm" class="letterlink">&nbsp;G&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_H.htm" class="letterlink">&nbsp;H&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_I.htm" class="letterlink">&nbsp;I&nbsp;</A></td>
     </tr><tr>
      <td align=center class="letter"><A href="../Merk/MP_J.htm" class="letterlink">&nbsp;J&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_K.htm" class="letterlink">&nbsp;K&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_L.htm" class="letterlink">&nbsp;L&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_M.htm" class="letterlink">&nbsp;M&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_N.htm" class="letterlink">&nbsp;N&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_O.htm" class="letterlink">&nbsp;O&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_P.htm" class="letterlink">&nbsp;P&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Q.htm" class="letterlink">&nbsp;Q&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_R.htm" class="letterlink">&nbsp;R&nbsp;</A></td>
     </tr><tr>
      <td align=center class="letter"><A href="../Merk/MP_S.htm" class="letterlink">&nbsp;S&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_T.htm" class="letterlink">&nbsp;T&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_U.htm" class="letterlink">&nbsp;U&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_V.htm" class="letterlink">&nbsp;V&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_W.htm" class="letterlink">&nbsp;W&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_X.htm" class="letterlink">&nbsp;X&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Y.htm" class="letterlink">&nbsp;Y&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Z.htm" class="letterlink">&nbsp;Z&nbsp;</A></td>
     </tr>
    </table>
    <DIV class="normal_font">&nbsp; <strong>Principe actif</strong></DIV>
    <table border="0" cellspacing="2" cellpadding="1" align="center">
     <TR>
      <TD Class="letter" Align="center"><A HRef="../Stof/IN_A.htm" Class="letterlink">&nbsp;A&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_B.htm" Class="letterlink">&nbsp;B&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_C.htm" Class="letterlink">&nbsp;C&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_D.htm" Class="letterlink">&nbsp;D&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_E.htm" Class="letterlink">&nbsp;E&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_F.htm" Class="letterlink">&nbsp;F&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_G.htm" Class="letterlink">&nbsp;G&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_H.htm" Class="letterlink">&nbsp;H&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_I.htm" Class="letterlink">&nbsp;I&nbsp;</A></TD>
     </TR><TR>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_J.htm" Class="letterlink">&nbsp;J&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_K.htm" Class="letterlink">&nbsp;K&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_L.htm" Class="letterlink">&nbsp;L&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_M.htm" Class="letterlink">&nbsp;M&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_N.htm" Class="letterlink">&nbsp;N&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_O.htm" Class="letterlink">&nbsp;O&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_P.htm" Class="letterlink">&nbsp;P&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Q.htm" Class="letterlink">&nbsp;Q&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_R.htm" Class="letterlink">&nbsp;R&nbsp;</A></TD>
     </TR><TR>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_S.htm" Class="letterlink">&nbsp;S&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_T.htm" Class="letterlink">&nbsp;T&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_U.htm" Class="letterlink">&nbsp;U&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_V.htm" Class="letterlink">&nbsp;V&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_W.htm" Class="letterlink">&nbsp;W&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_X.htm" Class="letterlink">&nbsp;X&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Y.htm" Class="letterlink">&nbsp;Y&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Z.htm" Class="letterlink">&nbsp;Z&nbsp;</A></TD>
     </TR>
    </TABLE>

   </TD>
<!--- einde van linker "tafel" met TOC --->

<!--- tussen kolommetje --->
   <TD Width="20"></TD>

<!--- begin van rechter "tafel" met ThGrp en M info --->
   <TD vAlign="top">
   
    <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
     <TR> 
      <TD RowSpan="2" Width="10"></TD>
      <TD Width="70%"><STRONG><FONT Face="Arial" Size="2">R&eacute;pertoire Comment&eacute; des M&eacute;dicaments</FONT></STRONG></TD> 
      <TD Width="29%" Align="Right" Class= "Datum">&nbsp;
       Avril 2015&nbsp;&nbsp;
      </TD>
      <TD Rowspan="2" Width="10"></TD>
     </TR>
     <TR>
      <TD Colspan="2"><HR Width="100%" Size="1" Color="green" NOSHADE></TD>
     </TR>
    </TABLE>

    <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
     <TR>
      <TD Width="10"><A Name="TiCv00846"></A>&nbsp;</TD>
      <TD><H2>M&eacute;dicaments de la d&eacute;pendance aux opiac&eacute;s</H2></TD>
      <TD Width="10">&nbsp;</TD>
     </TR>
     <TR>
      <TD Width="10">&nbsp;</TD>
      <TD vAlign="top">
<!---    Start van de HYR->INTRO informatie blok--->
<A Name="Topic_A"><B>Positionnement</B></A><UL Class="Text"> <LI Class="Text">Voir Folia de novembre 2009 <I>et</I> f&eacute;vrier 2010.</LI> <LI Class="Text">Le soutien psychosocial reste la base de la prise en charge du patient souffrant de d&eacute;pendance aux opiac&eacute;s; les m&eacute;dicaments ont une place importante mais uniquement comme traitement adjuvant.</LI> <LI Class="Text">La naltrexone, un antagoniste des r&eacute;cepteurs morphiniques centraux et p&eacute;riph&eacute;riques, peut &ecirc;tre indiqu&eacute;e en milieu sp&eacute;cialis&eacute; dans la d&eacute;pendance aux opiac&eacute;s apr&egrave;s une phase initiale de d&eacute;sintoxication, afin de stabiliser la situation. Elle est aussi parfois utilis&eacute;e dans le cadre du sevrage alcoolique (<I><A Class="text" HREF="MPG_JEA.htm">voir 10.5.1.</A></I>).</LI> <LI Class="Text">Un traitement de substitution consiste &agrave; remplacer l'usage ill&eacute;gal d'opiac&eacute;s par un usage contr&ocirc;l&eacute; de m&eacute;thadone (par voie orale) ou de bupr&eacute;norphine (par voie sublinguale). L'objectif est de diminuer l'envie (<I>craving</I>) d'opiac&eacute;s (l'h&eacute;ro&iuml;ne p. ex.) et de favoriser la r&eacute;int&eacute;gration sociale du toxicomane. La dose est augment&eacute;e progressivement jusqu&rsquo;&agrave; atteindre une dose d&rsquo;entretien optimale, souvent dans une fourchette allant de 60 &agrave; 100 mg par jour pour la m&eacute;thadone ou de 12 &agrave; 24 mg par jour pour la bupr&eacute;norphine. Un surdosage mais aussi un sous-dosage doivent &ecirc;tre &eacute;vit&eacute;s.</LI> <LI Class="Text">Le traitement de substitution doit &ecirc;tre supervis&eacute; par des personnes comp&eacute;tentes dans la probl&eacute;matique de la toxicomanie. Il importe de continuer &agrave; suivre le patient, et de d&eacute;livrer les m&eacute;dicaments dans un emballage s&eacute;curis&eacute; pour les enfants.</LI> <LI Class="Text">On utilise aussi l'association fixe de bupr&eacute;norphine et de naloxone comme traitement de substitution. Avec cette association, on s'attend &agrave; ce que, lors de l'utilisation de doses normales, la naloxone n'atteigne pas la circulation g&eacute;n&eacute;rale (suite &agrave; l'effet de premier passage h&eacute;patique). L'objectif de cette association est surtout de contrecarrer l'usage abusif par administration intraveineuse de comprim&eacute;s &eacute;cras&eacute;s: en cas d'administration intraveineuse, la naloxone va contrecarrer l'effet de la bupr&eacute;norphine et provoquer des manifestations de sevrage.</LI> <LI Class="Text">En cas de surdosage aigu aux opiac&eacute;s, on utilise la naloxone (<I><A Class="text" HREF="MPG_TAAF.htm">voir 20.1.1.6.</A></I>).</LI></UL>
<A Name="Topic_C"><B>Contre-indications principales</B></A><UL Class="Text"> <LI Class="Text">M&eacute;thadone et bupr&eacute;norphine: celles des analg&eacute;siques morphiniques (<I><A Class="text" HREF="MPG_HC.htm">voir 8.3.</A></I>).</LI> <LI Class="Text">Naltrexone: utilisation concomitante d'analg&eacute;siques morphiniques; insuffisance h&eacute;patique ou r&eacute;nale s&eacute;v&egrave;re.</LI> <LI Class="Text">Association bupr&eacute;norphine + naloxone: insuffisance h&eacute;patique s&eacute;v&egrave;re.</LI></UL>
<A Name="Topic_D"><B>Effets ind&eacute;sirables principaux</B></A><UL Class="Text"> <LI Class="Text">M&eacute;thadone et bupr&eacute;norphine: ceux des analg&eacute;siques morphiniques (<I><A Class="text" HREF="MPG_HC.htm">voir 8.3.</A></I>).</LI> <LI Class="Text"><B>M&eacute;thadone: allongement de l'intervalle QT avec risque de torsades de pointes.</B> Pour les facteurs de risque d'allongement de l'intervalle QT, <I><A Class="text" HREF="IntroF.htm#A622">voir Intro.6.2.2.</A></I></LI> <LI Class="Text">Naltrexone: troubles gastro-intestinaux, troubles du sommeil, agitation, douleurs articulaires, c&eacute;phal&eacute;es, rarement hallucinations.</LI></UL>
<A Name="Topic_T"><B>Grossesse et allaitement</B></A><UL Class="Text"> <LI Class="Text"><B>Analg&eacute;siques morphiniques: d&eacute;pression respiratoire et manifestations de sevrage chez le nouveau-n&eacute;.</B></LI> <LI Class="Text">L'utilisation d'analg&eacute;siques morphiniques en p&eacute;riode d'allaitement ne peut se faire qu'avec prudence.</LI> <LI Class="Text">En ce qui concerne les femmes enceintes d&eacute;pendantes aux opiac&eacute;s, voir Folia de d&eacute;cembre 2006.</LI></UL>
<A Name="Topic_E"><B>Interactions principales</B></A><UL Class="Text"> <LI Class="Text">M&eacute;thadone et bupr&eacute;norphine: les interactions des analg&eacute;siques morphiniques (<I><A Class="text" HREF="MPG_HC.htm">voir 8.3.</A></I>).</LI> <LI Class="Text"><B>M&eacute;thadone: risque accru de torsades de pointes en cas d'association &agrave; d'autres m&eacute;dicaments qui allongent l'intervalle QT (<I><A Class="text" HREF="IntroF.htm#A622">voir Intro.6.2.2.</A></I>).</B></LI> <LI Class="Text">Naltrexone: risque de manifestations graves de sevrage si des opiac&eacute;s sont encore utilis&eacute;s ou ont &eacute;t&eacute; utilis&eacute;s dans la semaine pr&eacute;c&eacute;dant l'instauration du traitement.</LI> <LI Class="Text">La bupr&eacute;norphine est un substrat du CYP3A4 (<I><A Class="text" HREF="IntroF.htm#Tbl1b">voir tableau Ib dans l'Introduction</A></I>).</LI> <LI Class="Text">La m&eacute;thadone est un substrat du CYP3A4 et un inhibiteur du CYP2D6 (<I><A Class="text" HREF="IntroF.htm#Tbl1b">voir tableau Ib dans l'Introduction</A></I>).</LI></UL>
<!---    Start van de MP blok(ken)--->
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv00847"></A><A Name="MPG_JECA"><B>M&eacute;thadone</B></A></P>
       <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
        <TR>
         <TD Width="10">&nbsp;</TD>
         <TD vAlign="top">
<!---    Start van de HYR->INTRO informatie blok--->
<P Class="Text">- La m&eacute;thadone peut &ecirc;tre prescrite en magistrale, p. ex. sous forme de capsules ou de sirop; les pr&eacute;parations magistrales &agrave; base de m&eacute;thadone utilis&eacute;es comme traitement de substitution dans le cadre du sevrage aux opiac&eacute;s ou de la r&eacute;duction des opiac&eacute;s, sont rembours&eacute;es. Les formules mentionn&eacute;es ici sont celles du &ldquo;Formulaire Th&eacute;rapeutique Magistral&rdquo;. Les comprim&eacute;s de m&eacute;thadone en sp&eacute;cialit&eacute; (<I><A Class="text" HREF="MPG_HCA.htm">voir 8.3.1.</A></I>) ne permettent pas d'adapter la dose.</P>
<P Class="Text"><B>Sirop 1 mg/ml</B> (utiliser toujours la m&ecirc;me concentration afin d'&eacute;viter les erreurs).</P><LI Class="Text">R/ M&eacute;thadone chlorhydrate cent milligrammes</LI>
<LI Class="Text">Acide citrique anhydre 100 mg</LI>
<LI Class="Text">Ar&ocirc;me de banane 100 mg</LI>
<LI Class="Text">Glyc&eacute;rol 10 g</LI>
<LI Class="Text">Sirop simple 40 g</LI>
<LI Class="Text">Eau conservante q.s. ad 100 ml (= 112 g)</LI></UL><P Class="Text"><B>Capsules</B> (la dose journali&egrave;re totale doit &ecirc;tre int&eacute;gr&eacute;e dans une seule capsule; la quantit&eacute; de 40 mg est utilis&eacute;e ici comme exemple)</P><LI Class="Text">R/ M&eacute;thadone chlorhydrate quarante milligrammes</LI>
<LI Class="Text">Guar 50 mg</LI>
<LI Class="Text">Excipient diluant A (lactose monohydrat&eacute; tr&egrave;s fin 99,5 g + silice collo&iuml;dale anhydre 0,50 g)</LI>
<LI Class="Text">q.s. pour 1 capsule</LI></UL>
        </TR>
       </TABLE>
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv00848"></A><A Name="MPG_JECB"><B>Bupr&eacute;norphine</B></A></P>

       <BR>
       <A Name="MP_00969"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Subutex
         <FONT Class="IR_MPG">(Reckitt Benckiser)</FONT></TD>
         <TD Width="30"><A HRef="http://www.dopage.be" Class="PT_MPG"  Target= "_blank"><IMG SRC="../Images/Dop.gif" onmouseover="return escape('Narcotiques, interdits en comp&eacute;tition')" Width="15" Height="15" Border="0" Align="absmiddle"></A></TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[bupr&eacute;norphine (chlorhydrate)]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">compr. (subling.)</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE209666&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE209666&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_JECB.htm#Vos_00453" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 1640580<BR><B>CTI</B>: 209666<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">7 x&nbsp;2mg </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><IMG vAlign="Top" Width="10" Height="16" SRC="../Images/B.gif"><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 10,64</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE209675&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE209675&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_JECB.htm#Vos_00459" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 1640598<BR><B>CTI</B>: 209675<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">7 x&nbsp;8mg </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><IMG vAlign="Top" Width="10" Height="16" SRC="../Images/B.gif"><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 23,40</TD>
        </TR>
        <TR>
         <TD Colspan="5" Class="MpNote_MPG"> (seulement pour le traitement de substitution; m&eacute;dicament sp&eacute;cialement r&eacute;glement&eacute;)</TD>
        </TR>
       </TABLE>
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv01896"></A><A Name="MPG_JECC"><B>Naltrexone</B></A></P>

       <BR>
       <A Name="MP_00982"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Nalorex
         <FONT Class="IR_MPG">(Bristol-Myers Squibb)</FONT></TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[naltrexone, chlorhydrate]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">compr. (s&eacute;c.)</TD>
        </TR>
        <TR vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE145406&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE145406&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_JECC.htm#Vos_02922" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 1485903<BR><B>CTI</B>: 145406<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">28 x&nbsp;50mg </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right">&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 71,72</TD>
        </TR>
       </TABLE>

       <BR>
       <A Name="MP_05875"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Naltrexone Accord
         <FONT Class="IR_MPG">(Accord)</FONT></TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[naltrexone, chlorhydrate]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">compr. (s&eacute;c.)</TD>
        </TR>
        <TR vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE374665&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=BE374665&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_JECC.htm#Vos_02922" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 3086428<BR><B>CTI</B>: 374665<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">28 x&nbsp;50mg </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right">&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 58,18</TD>
        </TR>
       </TABLE>
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv01900"></A><A Name="MPG_JECD"><B>Bupr&eacute;norphine + naloxone</B></A></P>

       <BR>
       <A Name="MP_04069"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Suboxone
         <FONT Class="IR_MPG">(Reckitt Benckiser)</FONT></TD>
         <TD Width="30"><A HRef="http://www.dopage.be" Class="PT_MPG"  Target= "_blank"><IMG SRC="../Images/Dop.gif" onmouseover="return escape('Narcotiques, interdits en comp&eacute;tition')" Width="15" Height="15" Border="0" Align="absmiddle"></A></TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[bupr&eacute;norphine (chlorhydrate)&nbsp;2mg  + naloxone (chlorhydrate)&nbsp;0,5mg  ]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">compr. (subling.)</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/359/001&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/359/001&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_JECD.htm#Vos_00452" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2464980<BR><B>CTI</B>: 289545<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">7&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><IMG vAlign="Top" Width="10" Height="16" SRC="../Images/B.gif"><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 11,60</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/359/002&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/359/002&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_JECD.htm#Vos_00452" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2464998<BR><B>CTI</B>: 289554<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">28&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><IMG vAlign="Top" Width="10" Height="16" SRC="../Images/B.gif"><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 32,10</TD>
        </TR>
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[bupr&eacute;norphine (chlorhydrate)&nbsp;8mg  + naloxone (chlorhydrate)&nbsp;2mg  ]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">compr. (subling.)</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/359/003&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/359/003&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_JECD.htm#Vos_00458" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2464964<BR><B>CTI</B>: 289563<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">7&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><IMG vAlign="Top" Width="10" Height="16" SRC="../Images/B.gif"><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 27,08</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/359/004&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/359/004&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_JECD.htm#Vos_00458" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2464972<BR><B>CTI</B>: 289572<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">28&nbsp;</TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><IMG vAlign="Top" Width="10" Height="16" SRC="../Images/B.gif"><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 87,74</TD>
        </TR>
        <TR>
         <TD Colspan="5" Class="MpNote_MPG"> (seulement pour le traitement de substitution; m&eacute;dicament sp&eacute;cialement r&eacute;glement&eacute;)</TD>
        </TR>
       </TABLE>
<!---
       <P Class="datum">
       <A Href="#TopOfPage">
        <IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A>&nbsp;</P>
--->
      </TD>
      <TD Width="10">&nbsp;</TD>
     </TR>
    </TABLE>
    <BR>
 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
  <TR>
   <TD Align="center">
    <HR WIDTH="90%" SIZE="1" COLOR="#008000" NOSHADE>
    <SPAN Class="footer">
 Centre Belge d 'Information Pharmacoth&eacute;rapeutique (C.B.I.P. asbl) <BR>
 c/o Heymans Instituut, De Pintelaan 185, 9000 Gent<BR>
 </SPAN>
 <A HRef="" Target="_top" Class="footer_link"><font color="#0000FF"></font></A> -
 <A HRef="mailto:redaction@cbip.be" Class="footer_link"><font color="#0000FF">redaction@cbip.be</font></A>
 - <A HRef="../Headertxt/Avertissement.htm" target="_blank" class="footer_link"><FONT Color="#0000FF">Avertissement / Disclaimer</FONT></A>
   </TD>
  </TR>
 </TABLE>
<!--- einde van de rechter "tafel" met MP info--->

   </TD>
  </TR>
 </TABLE>
<script language="JavaScript" type="text/javascript" SRC="../JS/wz_tooltip.js"></script>
</BODY>
</HTML>
<CFINCLUDE template="/search/incHighLightScriptJQuery.cfm">
